![]() Scholar Rock Scholar Rock is discovering and developing a new class of biologic therapies to selectively target dysregulated growth factors in the disease microenvironment by modulating supracellular activation, resulting in therapeutic effects specifically at the source of disease. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 2012 | Founding Date 1985 | Founding Date 1978 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 1401% increase | Employees 9,067 | Employees 7,605 |
Valuation ($) | Valuation ($) 2.8 b | Valuation ($) 4.2 b | Valuation ($) 26.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥4.1b (FY, 2025) | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥7.8b (FY, 2025) | Gross profit $7.5b (FY, 2025) |
Net income | Net income ($377.9m) (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income $1.3b (FY, 2025) |
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyBiogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company